Woodline Partners LP

Portfolio Companies 2026 for Woodline Partners LP: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Woodline Partners LP accounts for 7 tracked companies with verified cap-table data, 7 of which disclose round sizes totalling $2.1B. The median disclosed raise is $185M, and the largest is Point Biopharma at $650M, ahead of Mirador Therapeutics ($650M) and Tango Therapeutics ($225M).

The names that recur most often on these portfolio cap tables are Woodline Partners LP (7 companies), Farallon Capital Management (3 companies), Logos Capital (3 companies), Janus Henderson Investors (3 companies), RA Capital Management (2 companies), Surveyor Capital (2 companies). By latest disclosed round, the market skews Series B (4), IPO (1), Series A (1), Series D (1).

Best funded Woodline Partners LP companies

  1. Point Biopharma — $650M (latest: IPO)
  2. Mirador Therapeutics — $650M (latest: Series B)
  3. Tango Therapeutics — $225M (latest: Series A)
  4. LEXEO Therapeutics — $185M (latest: Series B)
  5. ShouTi — $158M (latest: Series B)
  6. Build A Rocket Boy — $110M (latest: Series D)
  7. Cedilla Therapeutics — $83M (latest: Series B)

Woodline Partners LP — related firms and companies (49)

Woodline Partners LP profile · All research reports